Overview

Study to Assess the Effect of Formoterol and Beclomethasone Dipropionate in Asthmatic Patients

Status:
Completed
Trial end date:
2010-08-01
Target enrollment:
Participant gender:
Summary
The objective of this study is to evaluate the effect of the combination of formoterol and beclometasone dipropionate on central and peripheral airway dimensions in asthmatic patients using Computational Fluid Dynamics (CFD). Further more, the effect of this combination therapy on exhaled NO, lung function (spirometry, body plethysmography, diffusion and resistance) and subjective asthma control score as well as the safety of this combination will be assessed.
Phase:
Phase 4
Details
Lead Sponsor:
Wilfried De Backer
Collaborator:
UCB Pharma
Treatments:
Beclomethasone
Formoterol Fumarate